Introduction
Hippocampal sclerosis (HS) is the most common pathology in the brain of patients with drug-resistant mesial temporal lobe epilepsy (MTLE). [1] [2] [3] [4] HS is present in 50-70% of cases in which a temporal lobectomy was performed for the treatment of refractory epilepsy. [5] [6] [7] Various studies have confirmed that MTLE-HS is a chronic disease characterised by prominent neuronal loss and fibrillary gliosis at the level of the hippocampal pyramidal cell layer, but the pathophysiological mechanisms of HS are not clear. 2, 8, 9 Early surgery is typically recommended because uncontrolled epilepsy is associated with cognitive impairment, psychosocial dysfunction, and increased morbidity and mortality. It has been found that if refractoriness is detected early, aggressive drug therapy or early surgery can improve the responsiveness to treatment and minimise these adverse effects. is a referral hospital for patients with epilepsy for the entire country and primarily serves a low-income population. The patients were diagnosed according to the criteria proposed by the International League Against Epilepsy (ILAE), which include seizure semiology, EEG, and magnetic resonance imaging (MRI) findings. 18 We only considered seizure semiology and MRI findings as the inclusion criteria. We did not consider EEG as an inclusion criterion because the standard 30-min EEG in patients with mesial temporal lobe epilepsy can be normal or indeterminate, which does not rule out the presence of MTLE-HS; ictal epileptiform activity is nearly all always detected using long-term EEG monitoring or repeated standard EEGs. 9 We conducted medical histories with an emphasis on seizure semiology. We conducted conventional EEGs using 18 digital channels for 30 min, following the international standards requiring the placement of 10-20 electrodes. The studies were conducted using an Intera1. The inclusion criteria for the study were the following: (1) clinical history and signs of epilepsy corresponding to MTLE, usually with auras that consisted of epigastric, autonomic, and/or psychic sensations followed by an arrest of motor activity, progressive loss of consciousness, and automatisms of the mouth and hands, with or without secondary generalisation; and (2) MRI findings: the presence of atrophy (coronal T1-IR) and/or increased hippocampal signal (coronal T2 and FLAIR) detected by visual analysis by 2 neuroradiologists). We analysed the following factors: age, gender, age at onset of epilepsy, history of febrile seizures, presence of TBI, infections of the central nervous system (CNS), perinatal injury, family history of epilepsy, interval between brain injury and onset of epilepsy, seizure frequency before the start of treatment with antiepileptic drugs, type of seizures, site of HS, extrahippocampal pathology, and alterations in the EEG.
We included patients who were at least five years old. The onset of epilepsy refers to the patient's age when the seizures started, excluding febrile seizures. The ability to distinguish between simple febrile seizures (generalised, shorter than 10 min, without recurrence within 24 h or during the duration of the febrile illness) and complex febrile seizures (present focal symptomatology, duration longer than 10 min, occurs two or more times within 24 h or during the duration of the febrile illness), 20 is problematic because of the amount of time that passes between the onset of a febrile seizure and the time at which the patient is first seen for their epileptic symptoms. The patients or their relatives are typically unable to remember the exact duration of the febrile seizure. Because of this difficulty, we did not differentiate between simple and complex febrile seizures. The identification of a patient as having a suspected CNS infection was primarily based on the history given by the patient or their relatives and the absence of other potential aetiological factors for their cases of epilepsy, e.g., history of significant head trauma, history of febrile convulsions, history of perinatal injury or non-febrile seizures preceding the suspected CNS infection.
One potential limitation of our study is that the primary criterion for the selection of a case of suspected CNS infection or perinatal asphyxia was the history provided by the patient or their relatives. It was not possible to obtain definitive confirmation of the precise nature of the reported event because it occurred many years before or was managed at another institution. Many of our native patients, particularly in rural areas, have home deliveries without medical assistance. TBI was considered when there was a loss of consciousness, post-traumatic amnesia, or focal neurological signs after a brain injury. 21 A family history of epilepsy was considered in patients who had relatives of at least first or seconddegree co-sanguinity with epilepsy. The interval between the brain injury and the occurrence of the first seizure could not be determined for all the subjects. The interval was established for 94 patients (85.5%). These brain injuries included: febrile seizures, perinatal asphyxia, CNS infections, and TBI. We considered brain injuries that occurred before the age of five. Mathern GW et al. (1995) , in a series of 20 patients, demonstrated that patients who suffered brain injuries before the age of five showed significant unilateral hippocampus atrophy versus those who did not. 22 The seizure frequency prior to the initiation of treatment was considered by calculating the median seizure frequency for the last three months. The seizure types included simple partial seizures, complex partial seizures, and secondarily generalised partial seizures. We included patients with unilateral or bilateral hippocampal sclerosis and those with additional extra-hippocampal pathology (''dual'' pathology) according to the findings of the MRI. Abnormal electroencephalographic findings included temporal intermittent rhythmic delta activity (TIRDA) and/or interictal epileptiform activity (IEA) of either spike or sharp wave type in the temporal regions, with maximum electronegativity in the anterior temple (F7/F8). Follow-up examinations were performed every two to three months. After two years of follow-up, the patients were divided on the basis of the outcomes after medical treatment into two groups. Group I was seizure free for at least two years, and Group II was not seizure free. 23 We compared the clinical, neurophysiological, and imaging factors across these two groups of patients using statistical methods. We made a note of any antiepileptic drugs used by the patients in both groups.
Statistical analysis
The statistical analyses were performed with SPSS software (IBM, Chicago, IL, USA).
The data are presented as the means, standard deviations, and percentages. The Kolmogorov-Smirnov test was used to determine the normality of the data distribution, and Levine's test was used to assess the homogeneity of variance. Analysis of variance (ANOVA) or the non-parametric Kruskal-Wallis test were used for continuous variables and normally distributed data. The Chi-squared test or Fisher's exact test (when the number of observations was too small) were used to compare the percentages. P values of <0.05 were considered statistically significant. For the multivariate analysis, we used the Logistic Regression Model with the Enter Method for variables selection, the Hosmer-Lemeshow test to determine the goodness of fit of the model (0.629) and the Wald test to determine the coefficients of each of the significant variables.
Results
Data regarding the clinical, neurophysiological, and neuroradiological factors for the 2 groups of patients are presented in Tables 1  and 2 . We identified 45 women (40.9%) and 65 men (59.1%). The patients' ages ranged from 8 to 53 years (mean = 31.3 AE 14.5 years). Thirty-four (31%) patients were in Group I, and 76 (69%) were in Group II. Of the 110 patients included in the study, 20 (18%) patients were already receiving monotherapy with subtherapeutic levels of carbamazepine (10 patients), oxcarbazepine (five patients), or valproic acid (five patients). Ninety (82%) patients were diagnosed for the first time at the time of the study. After two years of follow-up, of the 34 patients free of seizures, 20 patients (59%) were on monotherapy and 14 patients (41%) were receiving dual-therapy. Of the 76 patients who were not seizure free, 70 patients (92%) were receiving dual-therapy, and six patients (8%) were receiving triple-therapy (Table 3 ). Carbamazepine was the most frequently used antiepileptic drug for monotherapy. For dual-therapy, the combination of carbamazepine and levetiracetam was the most common. For triple-therapy, the most common combination was carbamazepine, valproic acid, and levetiracetam. We found 28 patients with right HS (25.5%), 62 patients with left HS (56.4%), and 20 patients with bilateral HS (18.1%). There were nine patients with extra hippocampal pathology (dual pathology): five patients with brain calcifications (one with left parietal with left HS, one with left occipital with left HS, two with left temporal calcifications, one with left HS and one with right HS, and one patient with multiple brain calcifications with bilateral HS) and four patients with malformations of cortical development (two patients with focal frontal dysplasia and hippocampal sclerosis on the same side, one patient with focal temporal dysplasia on the same side of hippocampal sclerosis, and one patient with subcortical nodular heterotopia on the same side as the hippocampal sclerosis). We found three patients with arachnoid cysts on the same side of the hippocampal sclerosis. Four patients in Group II had a history of a suspected CNS infection. The presence of secondarily generalised partial seizures or more than 10 seizures per month before treatment were associated with poor outcomes with regard to seizure frequency and seizure control. Among the 34 patients without seizures, 18 (53%) had interictal epileptiform activity with spikes (slow waves of 1 Hz) with maximum anterior temporal electronegativity in the unilateral temporal region, and 16 (47%) had normal EEG findings. Of the 76 patients who continued to have seizures, three (4%) had normal EEG findings. Of the remaining 73 patients, 52 (68%) had interictal epileptiform activity, sharp wave and/or spike-slow wave of 1 Hz with maximum anterior unilateral temporal electronegativity, eight patients (10.5%) presented unilateral (TIRDA), 11 patients (14.5%) had TIRDA and unilateral IEA, and two patients (3%) had asynchronous and independent bilateral interictal temporal activity.
When comparing Groups I and II, it became evident that an earlier age at the first seizure was associated with a poorer outcome than when the first seizure occurred later in life. A shorter interval between the lesion and the first seizure was associated with poor outcomes.
The multivariate analysis indicated that an earlier age at the first seizure, more than 10 seizures per month before treatment, and EEG abnormalities were independent predictors of a poor outcome (Table 4 ).
Other factors, including age, gender, family history of epilepsy, perinatal asphyxia, febrile seizures, history of status epilepticus, central nervous system infections, and extrahippocampal pathology, were not associated with the post-treatment outcomes with regard to seizure frequency and seizure control.
Discussion
We presented here a population of 110 cases of MTLE-HS who were selected based on semiologic and imaging (MRI of the brain) criteria. We did not include EEG findings in the criteria because the standard 30-min EEG in patients with mesial temporal lobe epilepsy can be normal or indeterminate, although this does not rule out the presence of MTLE-HE. Interictal epileptiform activity is frequently detected using long-term EEG monitoring or repeated standard EEGs. 19 Thirty-four patients (31%) remained seizure-free for at least two years while undergoing therapy with antiepileptic drugs, showing a range from 5% (Semah F et al. 2000) to 42% (Stephen L et al., 2001 ). 3 This relative high percentage of patients is likely due to our hospital being a referral centre for patients with epilepsy across the country and not solely for patients with difficult-to-control epilepsy. The majority of patients (76 or 69%) were not seizure free during the two years of treatment, in agreement with other published studies (Kim WJ et al., 1999; Pittau F et al., 2009 ). 1, 15 One limit of our study is the decision not to include EEG, as an inclusion criterion, which may limit the diagnosis of mesial temporal lobe epilepsy, with mild forms of hippocampal sclerosis; normally indicated histophatologically; this EEGs could indicate interictal epileptiform activity, even though the MRI would suggest otherwise (Holmes MD et al. 2000 ) 34 . In our study, we found nine patients (11%) with dual pathology, five of which showed cerebral calcifications accompanying HS. This suggests that brain CT (computed tomography) scans should be performed along with the brain MRI scan and EEG evaluations in countries where cysticercosis is endemic, as it is in Ecuador. Three of the patients in Group II were found to have temporal arachnoid cysts on the same side of the EH. Arachnoid cysts are considered incidental findings in patients with epilepsy and do not necessarily reflect the location of the epileptic centre. 24 The present study found that the presence of more than 10 seizures per month before treatment was a poor prognostic factor. This finding is consistent with other published findings, which have shown a worsened prognosis with an increased frequency of pre-treatment seizures. [25] [26] [27] [28] [29] Patients who had more than 10 seizures per month before treatment were more than twice as likely to develop refractory epilepsy than the patients who had fewer seizures. 27 The results or our work are not consistent with the results from a recent study (Gasparini S et al. 2013 ), 30 which
found that the frequency of seizures before the start of treatment was not a prognostic factor. This could be explained by differences in the patient populations studied because Gasparini et al. include patients with cryptogenic focal epilepsy and used hippocampal sclerosis as an exclusion criterion. The presence of abnormal EEG findings (temporal intermittent rhythmic delta activity and/or interictalepileptiform activity of spike or sharp wave type in the temporal regions with maximal anterior temporal electronegativity) was a negative predictor of seizure control with medical treatment. This result is consistent with previous studies. 1, 15, 31 . Methodological limitations, differences in how the EEGs are recorded, adoption of different criteria for ''abnormality'', and differences in EEG interpretation could alter the strength of abnormal activity as a predictor of outcomes. 15 We found that an earlier the onset of seizures has a worse prognosis. Although the early onset of seizures has been associated with a good prognosis, 32 the majority of evidence favours the conclusion that an early onset of seizures correlates with a poor prognosis. 1, 15, 16, 33 . On the univariate analysis, predictors of poor outcomes included an early onset of seizures, more than 10 seizures per month before treatment, EEG abnormalities, a shorter interval between the lesion and the first seizure, secondarily generalised partial seizures. The multivariate analysis showed an early onset of seizures, more than 10 seizures per month before treatment, and EEG abnormalities to be significant prognostic predictors of poor outcomes. We suggest that the early recognition of poor prognostic factors would allow for the identification of risk groups within the population of patients with MTLE-HS for development of a refractory condition to shorten treatment and introduce the possibility of epilepsy surgery. 11, [35] [36] [37] We believe that this early detection would help prevent neuropsychological and social degeneration in these patients.
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